Chief Executive Officer and Chairman of the Board
Co-founder of INVO Bioscience, Ms. Karloff has more than 30 years of experience in medical device and pharmaceutical manufacturing, clinical operations, regulatory affairs and quality systems. Katie has been critical to the FDA approval of the INVOcell device as well as the product development and scale-up of the INVOcell. Prior to INVO Bioscience, Katie was the Corporate Vice President of Operations for Psivida Ltd, a start up combination medical device/pharmaceutical technology company whereas she was critical in developing obtaining FDA approval of a novel ocular implant. Katie also served over 13 years at Boston Scientific in various operation functions and 10 years on the senior management teams of other start-up organizations. Katie has an undergraduate degree in Microbiology and MBA coursework from Northeastern University.
(978)-878-9505 ext. 504
Vice President Global Operations
Ms. Kahler first became part of the INVO Bioscience team as a consultant in 2010. Lori has over 25 years domestic and international experience in operations, quality, regulatory, compliance and clinical affairs, with proficiency across a full range of business functions and systems. Lori has successfully directed strategic programs to advance product performance and effectively gain market entry globally. Former founder and managing director of The RC Insight Group, Lori was instrumental in achieving FDA De Novo clearance for INVO Bioscience’s innovative INVOcell System. Positions Lori previously held include Director of Regulatory and Compliance for Samsung Electronics America (Health and Medical Equipment), Vice President of Regulatory and Clinical Operations for Ximedica, and Global Director of Quality Operations and Regulatory Affairs/ Managing Director Asia Pacific Region for Agfa Healthcare.
(978) 878-9505 x502
Mr. Bowdring joined the INVO Bioscience board in 2013. He is currently Chief Financial Officer at Dynasil Corporation a publicly traded company that develops and manufactures optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets. Prior to joining Dynasil in 2013, Rob served as the Chief Financial Officer for INVO Bioscience from 2008 until 2013. Previously he served as Chief Financial Officer of Cyphermint, Inc. from 2003 to 2008, and as Vice President and Corporate Controller for Lifeline Systems from 1989 to 2003. Prior to 1989, Rob held positions of increasing responsibility at Remanco, Inc., Warburton’s Inc., Cyborg Corporation, and Technogenics, Inc. Rob has a B.A. in Accounting from the University of Massachusetts.
Claude Ranoux, MD, MS
Founder and Director
Dr. Ranoux has more than 30 years of experience in the research and treatment of infertility; he is the inventor and developer of the INVOcell™ Device and Procedure. From 2000 through 2005, Dr. Ranoux served as President of Medelle Corporation and worked on the development of the INVOcell. Dr. Ranoux has built and run 12 IVF centers worldwide and has established 12 reproductive centers worldwide.
Before founding INVO Bioscience and recruiting the highly experienced management team, Dr. Ranoux had 6 years of experience in creating and finding financing for a startup company. He has been a scientific consultant for a new instrument (Immuno1) from Bayer Corporation.
Dr. Ranoux was the founder of several nonprofit organizations and foreign trade advisor in the New England area. Dr. Ranoux served as a scientific consultant for eight reproductive centers and is the author of numerous scientific publications as first author. He has given numerous invited lectures, conferences and workshops and is the author of five medical and scientific theses and mentor for several others. He is co-author of six scientific and medical films. He received a prize for one of the best scientific presentations at the Fifth World Congress in IVF, in Norfolk, VA, and is the recipient of several other awards. Dr. Ranoux is the main inventor in six international patents.
Dr. Ranoux earned his M.D. and his M.S. in Reproductive Biology from the Medical University of Paris (V & XI).
(978)-878-9505 ext. 506